The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients

Conclusions The results of this study suggest that amrubicin is active in patients with CNS metastases originating from SCLC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research